Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with ...

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks ...

Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...

The continent is being drenched in an avalanche of medical disinformation with the aim of undermining western influence ...

A: Tony Wood, Chief Scientific Officer, explained that GSK is prioritizing a 30-plus valent adult vaccine proposition due to its superior antigen coverage without diminishing immunogenicity.

GSK Philippines recently announced that announced on Tuesday that the Philippine Food and Drug Administration (FDA) has approved its Meningococcal Group B Vaccine (recombinant, adsorbed), for the ...

Sales of Established vaccines improved 10%. During the quarter, GSK did not record any sales from the COVID-19 booster vaccine co-developed in partnership with Sanofi SNY. Core selling ...

GSK reported core earnings per share of 49.7 pence on sales of £8.01 billion, compared with 43.6 pence on sales of about £8 billion in the analysts estimates. It kept full-year total sales and ...

GSK GSK-1.51%decrease; red down pointing triangle cut its full-year vaccine sales outlook after key shots for respiratory syncytial virus and shingles missed expectations in the third quarter due ...

U.K. drugmaker GSK on Wednesday cut its vaccine sales guidance for the year, citing lower-than-expected demand. The company said it’s now expecting a low single-digit fall in vaccine sales this ...

Also Read: Just After Pfizer’s RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population Specialty Medicine sales increased ...